AFP and hepatitis B virus infection: Dialysis patients exhibited higher rates of dual viral hepatitis B and C, lower serum alpha-fetoprotein levels, poorer performance status and greater model for end-stage liver disease scores than non-dialysis patients or matched controls (P < 0.05).